newsfilter
← Latest News
Business Wire·

AlloVir Announces Proposed Public Offering of Common Stock

AlloVir, Inc. (NASDAQ:ALVR), a late clinical-stage cell therapy company, today announced that it has commenced a proposed underwritten public offering of $75.0 million of shares of its common stock. AlloVir also intends